ResearcherUniversity Hospital CologneActive in the last 2 years
Peter Čamaj
Matched on OpenAlex author ID A5076996542. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2015: 3 papers · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 7
- Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. Co-author DOI 10.1007/s13402-025-01128-8↗
- Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. Co-author DOI 10.1007/s13402-020-00559-9↗
- Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-017-2351-4↗
- Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells. Co-author DOI 10.3892/ijo.2016.3512↗
- Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis. First author DOI 10.1007/s11523-014-0323-z↗
- Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pa… Last author DOI 10.1007/s11523-015-0360-2↗
- Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular "pseudoinflammation" contributing to an aggressiv… First author DOI 10.18632/oncotarget.2494↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christiane J. Bruns · 7 shared papers, 2015–2025 · strength 0.61
- Paper Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signal… DOI 10.1007/s13402-025-01128-8↗
- Paper Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. DOI 10.1007/s13402-020-00559-9↗
- Paper Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic … DOI 10.1007/s00432-017-2351-4↗
- Ioannis Pozios · 3 shared papers, 2017–2025 · strength 0.42
- Paper Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signal… DOI 10.1007/s13402-025-01128-8↗
- Paper Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. DOI 10.1007/s13402-020-00559-9↗
- Paper Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic … DOI 10.1007/s00432-017-2351-4↗
- Hendrik Seeliger · 3 shared papers, 2017–2025 · strength 0.42
- Paper Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signal… DOI 10.1007/s13402-025-01128-8↗
- Paper Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. DOI 10.1007/s13402-020-00559-9↗
- Paper Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic … DOI 10.1007/s00432-017-2351-4↗
- Lucas D. Lee · 2 shared papers, 2021–2025 · strength 0.36
- Paper Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signal… DOI 10.1007/s13402-025-01128-8↗
- Paper Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. DOI 10.1007/s13402-020-00559-9↗
- Nina A. Hering · 2 shared papers, 2021–2025 · strength 0.36
- Paper Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signal… DOI 10.1007/s13402-025-01128-8↗
- Paper Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. DOI 10.1007/s13402-020-00559-9↗
- Yue Zhao · 5 shared papers, 2015–2017 · strength 0.25
- Paper Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic … DOI 10.1007/s00432-017-2351-4↗
- Paper Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells. DOI 10.3892/ijo.2016.3512↗
- Paper Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular "pseudoin… DOI 10.18632/oncotarget.2494↗
- Hanno Nieß · 4 shared papers, 2015–2017 · strength 0.20
- Paper Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic … DOI 10.1007/s00432-017-2351-4↗
- Paper Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular "pseudoin… DOI 10.18632/oncotarget.2494↗
- Paper Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and met… DOI 10.1007/s11523-014-0323-z↗
- Felix Popp · 1 shared paper, 2017 · strength 0.06
- Thomas Knösel · 1 shared paper, 2017 · strength 0.06
- Utz Settmacher · 1 shared paper, 2017 · strength 0.06
- Lu Zhao · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.